Hansa Biopharma AB (HNSA) — Financial Flexibility Index
Hansa Biopharma AB (HNSA) has a Financial Flexibility Index of -0.09x as of June 2025. Free cash flow of Skr-111.70 Million (operating CF Skr-111.70 Million minus capex Skr0.00) represents 0% of total liabilities (Skr1.28 Billion). Check total reinvestment intensity of Hansa Biopharma AB to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hansa Biopharma AB Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hansa Biopharma AB across 17 annual periods. For the full cash flow conversion analysis, see Hansa Biopharma AB cash flow conversion.
Annual Financial Flexibility Index for Hansa Biopharma AB (2008–2024)
Year-by-year free cash flow to debt coverage for Hansa Biopharma AB. Explore HNSA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.49x | Skr-674.77 Million | Skr-674.88 Million | Skr1.39 Billion | ▲ +23.8% |
| 2023 | -0.64x | Skr-755.37 Million | Skr-755.65 Million | Skr1.19 Billion | ▼ -38.3% |
| 2022 | -0.46x | Skr-499.40 Million | Skr-502.73 Million | Skr1.08 Billion | ▲ +75.5% |
| 2021 | -1.88x | Skr-478.77 Million | Skr-481.17 Million | Skr255.24 Million | ▼ -24.4% |
| 2020 | -1.51x | Skr-289.98 Million | Skr-290.27 Million | Skr192.37 Million | ▲ +53.9% |
| 2019 | -3.27x | Skr-331.35 Million | Skr-334.77 Million | Skr101.42 Million | ▼ -37.3% |
| 2018 | -2.38x | Skr-202.07 Million | Skr-204.56 Million | Skr84.94 Million | ▲ +19.9% |
| 2017 | -2.97x | Skr-147.70 Million | Skr-150.10 Million | Skr49.75 Million | ▲ +14.4% |
| 2016 | -3.47x | Skr-93.58 Million | Skr-94.56 Million | Skr26.98 Million | ▲ +22.9% |
| 2015 | -4.50x | Skr-56.48 Million | Skr-57.80 Million | Skr12.56 Million | ▲ +9.6% |
| 2014 | -4.97x | Skr-22.42 Million | Skr-23.62 Million | Skr4.51 Million | ▼ -71.3% |
| 2013 | -2.90x | Skr-14.80 Million | Skr-14.87 Million | Skr5.10 Million | ▲ +58.6% |
| 2012 | -7.01x | Skr-17.93 Million | Skr-20.63 Million | Skr2.56 Million | ▼ -59.9% |
| 2011 | -4.39x | Skr-27.14 Million | Skr-27.14 Million | Skr6.19 Million | ▼ -36.6% |
| 2010 | -3.21x | Skr-18.09 Million | Skr-18.09 Million | Skr5.64 Million | ▼ -208.2% |
| 2009 | -1.04x | Skr-13.78 Million | Skr-13.79 Million | Skr13.23 Million | ▲ +63.0% |
| 2008 | -2.82x | Skr-11.64 Million | Skr-15.58 Million | Skr4.13 Million | — |